Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Terminated2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT06270082Phase 1Terminated
Study of IK-595 in RAS- or RAF-altered Advanced Tumors
BRAF Gene MutationColorectal CancerCRAF Gene Mutation+7 more
StudychairStart date: 2023-12-18
NCT05228015Phase 1Terminated
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors
Epithelioid Hemangioendothelioma (EHE)Malignant Pleural Mesothelioma (MPM)NF2 Deficiency+5 more
StudychairStart date: 2022-01-07

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Katherine Kim, MD

Ikena Oncology

Very Similar
2 trials

Shared therapeutic areas:

Advanced Solid TumorsEpithelioid Hemangioendothelioma (EHE)Malignant Pleural Mesothelioma+6 more

Worked with same sponsors:

Ikena Oncology
Collaborated on 1 trial
Similarity Score94%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaCarcinoma, Non-Small-Cell LungCancer of Pancreas+2 more
Similarity Score8%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Solid Tumor, AdultCancer of PancreasColorectal Cancer+2 more
Similarity Score8%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungColorectal CancerAdvanced Solid Tumors+1 more
Similarity Score6%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Solid TumorSolid Tumor, AdultMalignant Glioma+1 more
Similarity Score6%

lin shen

Peking University Cancer Hospital & Institute

Related
31 trials

Shared therapeutic areas:

Advanced Solid TumorsColorectal CancerSolid Tumor+1 more
Similarity Score6%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungAdvanced Solid TumorsSolid Tumor
Similarity Score5%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of PancreasThyroid Carcinoma
Similarity Score5%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Cancer of PancreasThyroid CarcinomaColorectal Cancer
Similarity Score5%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of PancreasColorectal CancerSolid Tumor
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06270082Phase 1StudyChair

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

BRAF Gene MutationColorectal CancerCRAF Gene Mutation+7 more
Terminated
NCT05228015Phase 1StudyChair

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Epithelioid Hemangioendothelioma (EHE)Malignant Pleural Mesothelioma (MPM)NF2 Deficiency+5 more
Terminated

All 2 trials loaded